AU2824700A - Chemically modified g-csf preparations - Google Patents

Chemically modified g-csf preparations

Info

Publication number
AU2824700A
AU2824700A AU28247/00A AU2824700A AU2824700A AU 2824700 A AU2824700 A AU 2824700A AU 28247/00 A AU28247/00 A AU 28247/00A AU 2824700 A AU2824700 A AU 2824700A AU 2824700 A AU2824700 A AU 2824700A
Authority
AU
Australia
Prior art keywords
chemically modified
csf preparations
csf
preparations
chemically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28247/00A
Inventor
Kunio Ito
Yasuki Kato
Noboru Konishi
Yuji Ueno
Motoo Yamasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU2824700A publication Critical patent/AU2824700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU28247/00A 1999-03-01 2000-03-01 Chemically modified g-csf preparations Abandoned AU2824700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/52751 1999-03-01
JP5275199 1999-03-01
PCT/JP2000/001204 WO2000051626A1 (en) 1999-03-01 2000-03-01 Chemically modified g-csf preparations

Publications (1)

Publication Number Publication Date
AU2824700A true AU2824700A (en) 2000-09-21

Family

ID=12923616

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28247/00A Abandoned AU2824700A (en) 1999-03-01 2000-03-01 Chemically modified g-csf preparations

Country Status (2)

Country Link
AU (1) AU2824700A (en)
WO (1) WO2000051626A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005025600A1 (en) * 2003-09-11 2006-11-16 学校法人東海大学 Drugs that inhibit the recruitment of adherent cells to peripheral blood
KR101810191B1 (en) 2016-09-21 2017-12-19 연세대학교 산학협력단 Use of stem cell growth factor or fragments thereof for the inhibition of cell adhesion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4242919A1 (en) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Process for the preparation of storage-stable aqueous pharmaceutical preparations of G-CSF
US5824784A (en) * 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods

Also Published As

Publication number Publication date
WO2000051626A1 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
AU2955200A (en) Cannula
AU5259100A (en) Medicament
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU7106600A (en) Brownfields investing
AU2919001A (en) Syringe
AU5967600A (en) Candystraw
AU6335000A (en) Depthimeter
AU4115400A (en) Short-circuiter
AU1645700A (en) Oenothein medicaments
AU2804600A (en) Arylaminoalkylamides
AU2023701A (en) Sketcher
AU6440900A (en) Homogentisate-dioxygenase
AU2699800A (en) Organoceramics
AU1541601A (en) Syringes
AU4916900A (en) Benzofuranylsulfonates
AU3191100A (en) Ligand-bonded complex
AU4561600A (en) Benzofuranylaminoalcohols
AU1901801A (en) Glucofuranoses
AU2824700A (en) Chemically modified g-csf preparations
AU3133400A (en) Syringe
AU4435300A (en) Hula-hoop
AU1915601A (en) Periotome
AU2582200A (en) Windturbine
AU4504201A (en) Drug preparations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase